Healthcare & Life Sciences
Pharvaris
Germanywww.pharvaris.com/
Pharvaris is a series c plus startup based in Switzerland. 1 investor tracked.
Activeseries-c-plus
series-c-plus
Stage
2019
Founded
4
Investors
About Pharvaris
Pharvaris is a company founded in 2019 headquartered in Germany. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
Pharvaris is a clinical-stage biopharmaceutical company developing novel oral bradykinin B2 receptor antagonists. Their primary focus is on treating hereditary angioedema (HAE) and other bradykinin-mediated diseases.
Explore Pharvaris's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.